The 22nd Orphan Drugs & Rare Diseases Global Congress 2024 Americas is dedicated to the critical issues shaping the future of Orphan Drugs in the Americas.
Key Topics
How commercially viable Is It to Engage in the Development of Orphan Drugs?
Trends and Deal Structures in Licensing Agreements
Coming Together in Developing Orphan Drugs and Crossing Borders
Finding innovative and alternative ways in funding the development of Orphan Drugs
What is Orphan Drugs’ role in sustainability of the Pharmaceutical Industry?
What Do Developers Look for When Looking for an Outsourcing Partner?
Patient Access: How Can This Continue to Improve?
How Can the Developer and the Patient Assist in the Evolution and Development of Orphan Drugs?
What Do Insurance Companies Think About Orphan Drugs? Will They Make Modifications to Their Policies to Support Patients with Rare Diseases?
Who should Attend
Senior attendees with responsibilities in:
Personalised Medicine
Research and Development
External R&D Innovation
Regenerative Medicine
Rare and Ultra-Rare Diseases
Innovative Medicine
Cell and Gene Therapy
Therapeutic Are Lead
Molecular Geneticist
Translational Science
Patient Advocacy Groups
Program Management
Public Affairs
Patient Engagement
Regulatory Affairs
Medical Affairs
Market Access
Clinical Research Organizations
Pricing and Reimbursement
Managed and Early Access
Commercial Development
Health Economics Outcomes Research
Product Specialist
Investments and Funding
Business Planning and Operations
Global Strategic Services
Academia
Speciality Pharmacies
Past Events
22nd Orphan Drugs & Rare Diseases Global Congress 2024 Americas - 14-15 Nov 2024, Boston, Massachusetts, United States (92972)
Orphan Drugs & Rare Diseases Global Congress Americas 2026
Important
Please, check "Orphan Drugs & Rare Diseases Global Congress Americas" official website for possible changes, before making any traveling arrangements
